Ciongoli Gregory Austin
- SEC CIK
- 0002023732
In the past year, 1 open-market purchase filing worth $949.4K and no sales.
Current role at each company
- GOSS Gossamer Bio, Inc.Directoras of Sep 25, 2026
- RGNX REGENXBIO Inc.Directoras of Aug 27, 2026
- ATRA Atara Biotherapeutics, Inc.Director, 10% Owner, Other: See Remarksas of Jun 11, 2026
- ZYME Zymeworks Inc.Directoras of Jan 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $949.4K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$949.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ciongoli Gregory Austin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RGNX REGENXBIO Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 (view filing)7:03 PM ET | Aug 26-27 | 1 day | Ciongoli Gregory AustinDirector | PPurchase | +102.6K | $9.25 | +$949.4K | +664.9%118.0K after | 2 lots |